Last reviewed · How we verify

NCT03166137

Carbon Dioxide Laser and Cryotherapy in Treatment of Warts

Status unknown NA Last updated 25 May 2017
What this trial tests

NA trial testing Carbon dioxide laser in Common Warts in 60 participants. Status unknown.

Timeline
1 August 2017
Primary endpoint
1 August 2018
1 August 2019

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 August 2017
Primary completion1 August 2018
Estimated completion1 August 2019

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Common Warts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Viral warts are common skin conditions seen in both children and adults. Human papilloma virus is responsible for verrucae. Cutaneous manifestation of the human papillomavirus, are extremely common particularly on the hands and feet. Warts can induce hard, thickened skin, black pinpoints, pain or tenderness with significant morbidity for the patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Carbon dioxide laser

Trials testing the same drug.

Other recruiting trials for Common Warts

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03166137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing